Related Experiment Video
Updated: Mar 18, 2026

07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.3K
Noncoding RNAs: New Players in Cancers
Xueman Chen1, Siting Fan1, Erwei Song2
1Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou, China.
Advances in Experimental Medicine and Biology
|July 5, 2016
Summary
Noncoding RNAs (ncRNAs) are key regulators in development and disease, especially cancers. This review covers microRNAs, long ncRNAs, and circular RNAs, their functions, and roles in malignancy.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Noncoding RNAs (ncRNAs) are increasingly recognized for their critical roles in biological regulation.
- These molecules, including microRNAs (miRNAs), long ncRNAs (lncRNAs), and circular RNAs (circRNAs), are implicated in various developmental processes and diseases, particularly human cancers.
Purpose of the Study:
- To review the current understanding of the noncoding RNA field.
- To discuss the genomic context, biological functions, and mechanisms of action of miRNAs, lncRNAs, and circRNAs.
- To highlight the involvement of ncRNA dysregulation in human cancer initiation and progression.
Main Methods:
- Literature review of ncRNA research.
- Analysis of genomic context and biological functions.
- Examination of mechanisms of action and implications in disease.
Main Results:
- Noncoding RNAs encompass diverse types like miRNAs, lncRNAs, and circRNAs, each with distinct regulatory roles.
- The precise mechanisms of action for many ncRNAs are still under investigation.
- Dysregulation in the biogenesis and gene expression of ncRNAs is linked to cancer development.
Conclusions:
- Noncoding RNAs are vital regulators with significant implications in human health and disease.
- Further research into ncRNA mechanisms is crucial for understanding and treating diseases like cancer.
- Targeting ncRNA pathways holds potential for future therapeutic strategies in oncology.
Related Concept Videos
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs
3.8K
3.8K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Rous Sarcoma Virus (RSV) and Cancer
6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer
5.9K
5.9K

